FLANIGAN'S REPORTS EARNINGS
Tweet
Share
E-mailFORT LAUDERDALE, Fla., Jan. 25, 2023 /PRNewswire/ -- FLANIGAN'S ENTERPRISES, INC., (NYSE AMERICAN: BDL) owners and operators of the "Flanigan's Seafood Bar and Grill" restaurants and "Big Daddy's" retail liquor stores, announced results for the 13 weeks and the 52 weeks ended October 1, 2022. The table below sets forth the results on a comparative basis with the 13 weeks and the 52 weeks ended October 2, 2021.
13 Weeks Ended | 13 Weeks Ended | ||||||||
REVENUES | October 1, 2022 | October 2, 2021 | |||||||
RESTAURANT FOOD AND BAR SALES | $ | 31,642,000 | $ | 27,687,000 | |||||
PACKAGE STORE SALES | 7,407,000 | 5,381,000 | |||||||
FRANCHISE RELATED REVENUES | 442,000 | 421,000 | |||||||
RENTAL INCOME | 203,000 | 107,000 | |||||||
OTHER OPERATING INCOME | 30,000 | 39,000 | |||||||
TOTAL REVENUES | $ | 39,724,000 | $ | 33,635,000 | |||||
NET INCOME ATTRIBUTABLE TO | |||||||||
FLANIGAN'S ENTERPRISES, INC. | $ | 1,253,000 | $ | 1,354,000 | |||||
NET INCOME PER COMMON SHARE | |||||||||
BASIC AND DILUTED | $ | 0.68 | $ | 0.73 | |||||
52 Weeks Ended | 52 Weeks Ended | ||||||||
October 1, 2022 | October 2, 2021 | ||||||||
RESTAURANT FOOD AND BAR SALES | $ | 123,627,000 | $ | 105,298,000 | |||||
PACKAGE STORE SALES | 31,692,000 | 29,304,000 | |||||||
FRANCHISE RELATED REVENUES | 1,826,000 | 1,673,000 | |||||||
RENTAL INCOME | 814,000 | 770,000 | |||||||
OTHER OPERATING INCOME | 173,000 | 262,000 | |||||||
TOTAL REVENUES | $ | 158,132,000 | $ | 137,307,000 | |||||
NET INCOME ATTRIBUTABLE TO | |||||||||
FLANIGAN'S ENTERPRISES, INC. | $ | 6,312,000 | $ | 11,784,000 | |||||
NET INCOME PER COMMON SHARE | |||||||||
BASIC AND DILUTED | $ | 3.40 | $ | 6.34 | |||||
View original content:https://www.prnewswire.com/news-releases/flanigans-reports-earnings-301730923.html
SOURCE FLANIGAN'S ENTERPRISES, INC.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Worthington Steel, Inc. (WS) Misses Q4 EPS by 3c
- L'OFFICIEL AMTD IDEA Sets 2026 Launch for L'OFFICIEL Taiwan and L'OFFICIEL 时装 Singapore
- Innovent's Partner Ollin Biosciences Announces Oversubscribed $330 Million Series B Financing to Advance Global Phase 3 Development of IBI324 (OLN324) in DME and Wet AMD; Studies Commencing in Second
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
